» Articles » PMID: 21107436

The Isfahan Cohort Study: Rationale, Methods and Main Findings

Overview
Journal J Hum Hypertens
Date 2010 Nov 26
PMID 21107436
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

A 10-year longitudinal population-based study, entitled the Isfahan Cohort Study (ICS) is being conducted. The ICS commenced in 2001, recruiting individuals aged 35+ living in urban and rural areas of three counties in central Iran, to determine the individual and combined impact of various risk factors on the incidence of cardiovascular events. After 24379 person-years of follow-up with a median follow-up of 4.8 years, we documented 219 incident cases of ischemic heart disease (IHD) (125 in men and 94 in women) and 57 incident cases of stroke (28 in men and 29 in women). The absolute risk of IHD was 8.9 (7.8-10.2) per 1000 person-years for all participants, 10.6 (8.8-12.5) per 1000 person-years for men and 7.4 (6.0-9.0) per 1000 person-years for women. The respective risk of ischemic stroke was 2.3 (1.7-3.0), 2.3 (1.6-3.3) and 2.3 (1.5-3.2) per 1000 person-years. The risk of IHD was approximately 3.5-fold higher in the presence of hypertension, followed by diabetes mellitus and hypercholesterolemia with near 2.5- and twofold higher risk, respectively. This cohort provides confirmatory evidence of the ethnic differences in the magnitude of the impact of various risk factors on cardiovascular events. The differences may be due to varying absolute risk levels among populations and the existing ethnic disparities for using western risk equations to local requirements.

Citing Articles

Tea and coffee consumption and the 15-Year risk of cardiovascular events: the Isfahan cohort study (ICS).

Amani-Beni R, Sadeghi M, Nouri F, Darouei B, Mohammadifard N, Boshtam M Nutr J. 2025; 24(1):30.

PMID: 40001172 PMC: 11853883. DOI: 10.1186/s12937-025-01093-w.


Comparing the association of novel Anthropometric and atherogenicity indices with all-cause, cardiovascular and non-cardiovascular mortality in a general population of Iranian adults.

Hajihashemi P, Mohammadifard N, Bateni M, Haghighatdoost F, Boshtam M, Najafian J Am J Prev Cardiol. 2025; 21:100936.

PMID: 39967963 PMC: 11833613. DOI: 10.1016/j.ajpc.2025.100936.


Sex disparity in the burden of NCDs and its four main subgroups in Iran 1990-2019: a systematic analysis from the global burden of disease study 2019.

Fatollahzade M, Bastan M, Shaabanian M, Golestani A, Tabatabaei-Malazy O, Mohajeri-Tehrani M J Diabetes Metab Disord. 2024; 23(2):2207-2224.

PMID: 39610498 PMC: 11599546. DOI: 10.1007/s40200-024-01489-1.


Accuracy of novel anthropometric indices for assessing the risk for progression of prediabetes to diabetes; 13 years of results from Isfahan Cohort Study.

Fakhrolmobasheri M, Shafie D, Manshaee B, Karbasi S, Mazroui A, Najafabadi M Arch Endocrinol Metab. 2024; 68:e230269.

PMID: 39420936 PMC: 11460962. DOI: 10.20945/2359-4292-2023-0269.


Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS).

Rafiee H, Mohammadifard N, Nouri F, Tabatabaei G, Najafian J, Sadeghi M Eur J Med Res. 2024; 29(1):135.

PMID: 38368388 PMC: 10874543. DOI: 10.1186/s40001-024-01728-4.